Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Related Articles by Review for PubMed (Select 23386588)

1.

The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland.

Gillespie P, O'Shea E, Cullinan J, Lacey L, Gallagher D, Ni Mhaolain A; B. Lawlor for the Enhancing Care in Alzheimer's Disease (ECAD) Study Team.

Int J Geriatr Psychiatry. 2013 Mar;28(3):256-64. doi: 10.1002/gps.3819. Epub 2012 May 30.

PMID:
23386588
2.

The cost of dementia in Europe: a review of the evidence, and methodological considerations.

Jönsson L, Wimo A.

Pharmacoeconomics. 2009;27(5):391-403. doi: 10.2165/00019053-200927050-00004. Review.

PMID:
19586077
3.

Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.

Lamb HM, Goa KL.

Pharmacoeconomics. 2001;19(3):303-18. Review.

PMID:
11303418
4.

Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.

Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S.

Am J Manag Care. 2001 Aug;7(8):809-18. Review.

5.

Health state values for use in the economic evaluation of treatments for Alzheimer's disease.

Shearer J, Green C, Ritchie CW, Zajicek JP.

Drugs Aging. 2012 Jan 1;29(1):31-43. doi: 10.2165/11597380-000000000-00000. Review.

PMID:
22191721
6.

Donepezil for dementia due to Alzheimer's disease.

Birks J, Harvey RJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001190. Review.

PMID:
16437430
7.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
8.

Economic considerations in the treatment and management of Alzheimer's disease.

Schumock GT.

Am J Health Syst Pharm. 1998 Nov 1;55 Suppl 2:S17-21. Review.

PMID:
9809107
9.

Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease.

Plosker GL, Lyseng-Williamson KA.

Pharmacoeconomics. 2005;23(2):193-206. Review.

PMID:
15748093
10.

An economic perspective on Alzheimer's disease.

Trabucchi M.

J Geriatr Psychiatry Neurol. 1999 Spring;12(1):29-38. Review.

PMID:
10447152
11.

Vitamin E for Alzheimer's dementia and mild cognitive impairment.

Farina N, Isaac MG, Clark AR, Rusted J, Tabet N.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD002854. doi: 10.1002/14651858.CD002854.pub3. Review.

PMID:
23152215
12.

Economic considerations of Alzheimer's disease and related disorders.

Michel JP, Zekry D, Mulligan R, Giacobini E, Gold G.

Aging (Milano). 2001 Jun;13(3):255-60. Review.

PMID:
11442307
13.

Vitamin E for Alzheimer's disease and mild cognitive impairment.

Isaac MG, Quinn R, Tabet N.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD002854. doi: 10.1002/14651858.CD002854.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002854.

PMID:
18646084
14.

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.

15.

Alzheimer's disease: the strength of association of costs with different measures of disease severity.

Mauskopf J, Racketa J, Sherrill E.

J Nutr Health Aging. 2010 Oct;14(8):655-63. Review.

PMID:
20922342
16.

Comparison of informal care time and costs in different age-related dementias: a review.

Costa N, Ferlicoq L, Derumeaux-Burel H, Rapp T, Garnault V, Gillette-Guyonnet S, Andrieu S, Vellas B, Lamure M, Grand A, Molinier L.

Biomed Res Int. 2013;2013:852368. doi: 10.1155/2013/852368. Epub 2012 Dec 5. Review.

17.

Dependence as a unifying construct in defining Alzheimer's disease severity.

McLaughlin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan JM, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Y.

Alzheimers Dement. 2010 Nov;6(6):482-93. doi: 10.1016/j.jalz.2009.09.004. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk